RIL
IMRX icon

Rothschild Investment LLC’s Immuneering IMRX Stock Holding History

Rothschild Investment LLC’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25K Buy
+250
New +$1.26K ﹤0.01% 2973

Other funds holding IMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rothschild Investment LLC's IMRX Position: Q2 2026 in Review

Rothschild Investment LLC opened a new position in Immuneering (IMRX) in Q2 2026: 250 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #2973 among its holdings.

39 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Rothschild Investment LLC held 250 shares of Immuneering worth $1.25K as of Q2 2026.
  • Immuneering was a new Rothschild Investment LLC position in Q2 2026.
  • Immuneering made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2973 holding.
  • 39 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.